Regulatory Briefs: Pre-Submission Program Final Guidance; FDA Meetings; HHS Health IT Nominations
This article was originally published in The Gray Sheet
Executive Summary
FDA issues final guidance on its pre-submission program. The agency announced upcoming Gastroenterology and Urology Devices advisory panel meetings and a workshop for its Medical Device Epidemiology Network. More regulatory news.
You may also be interested in...
UDI, Device Pricing, Interoperability Issues Raised In Comments To Senators
In response to the Senate Finance Committee’s June request for comments on health care data sharing, the Pew Charitable Trust encouraged advances in the unique device identifier system. Industry representatives insist sharing of device price data is the wrong approach.
FDA Expands Partnerships With Universities As Part Of MDEpiNet Program
Yale had teamed up with Medtronic in one new FDA-funded project to improve post-market surveillance and use of registries. Duke University and the University of Washington have also received grants.
Industry Says FDA Should Broaden Scope Of Pre-Submission Program
FDA should allow pre-submission meetings to occur earlier in a device’s development cycle than what is stated in the recent draft guidance, industry groups say. The agency should also agree to review prior data as part of these meetings.